Evidence map›Paper›PMID 37382893›Full record

ArticleThe Journal of experimental medicine2023

Promiscuous recognition of MR1 drives self-reactive mucosal-associated invariant T cell responses.

Andrew Chancellor, Robert Alan Simmons, Rahul C Khanolkar, Vladimir Nosi, Aisha Beshirova, Giuliano Berloffa, Rodrigo Colombo, Vijaykumar Karuppiah, Johanne M Pentier, Vanessa Tubb and 20 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. ImmTAC: A Novel Platform of T-Cell Receptor-Based Soluble Bispecifics.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  5. Article
  6. Review
  7. Mitochondria regulate MR1 protein expression and produce self-metabolites that activate MR1-restricted T cells.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. MR1 presents vitamin B6-related compounds for recognition by MR1-reactive T cells.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 6 institutions in 3 countries.

Andrew Chancellor *Experimental Immunology, Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.ORCID 0000-0001-9658-4124
Robert Alan Simmons *Immunocore Ltd. , Abingdon, UK.ORCID 0000-0001-8417-6641
Rahul C KhanolkarImmunocore Ltd. , Abingdon, UK.ORCID 0009-0001-0037-3013
Vladimir NosiExperimental Immunology, Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.ORCID 0009-0007-3759-9116
Aisha BeshirovaExperimental Immunology, Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.ORCID 0000-0001-9434-3423
Giuliano BerloffaExperimental Immunology, Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.ORCID 0000-0003-3152-9858
Rodrigo ColomboExperimental Immunology, Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.ORCID 0009-0002-8641-6252
Vijaykumar KaruppiahImmunocore Ltd. , Abingdon, UK.ORCID 0000-0002-9645-7958
Johanne M PentierImmunocore Ltd. , Abingdon, UK.ORCID 0009-0007-7772-6853
Vanessa TubbImmunocore Ltd. , Abingdon, UK.ORCID 0000-0002-5199-8494
Hemza GhadbaneImmunocore Ltd. , Abingdon, UK.ORCID 0009-0001-8559-8245
Richard J SucklingImmunocore Ltd. , Abingdon, UK.ORCID 0000-0002-6962-6533
Keith PageImmunocore Ltd. , Abingdon, UK.ORCID 0000-0003-0717-396X
Rory M CreanDepartment of Biology and Biochemistry, University of Bath, Bath, UK.ORCID 0000-0003-4709-5353
Alessandro VacchiniExperimental Immunology, Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.ORCID 0000-0001-5473-9693
Corinne De GregorioExperimental Immunology, Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.ORCID 0000-0002-9520-9135
Verena SchaeferExperimental Immunology, Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.ORCID 0000-0001-7507-5435
Daniel ConstantinExperimental Immunology, Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.ORCID 0000-0003-3896-6428
Thomas GligorisImmunocore Ltd. , Abingdon, UK.ORCID 0000-0002-5724-2954
Angharad LloydImmunocore Ltd. , Abingdon, UK.ORCID 0000-0003-4569-9276
Miriam HockImmunocore Ltd. , Abingdon, UK.ORCID 0009-0007-4353-3738
Velupillai SrikannathasanImmunocore Ltd. , Abingdon, UK.ORCID 0000-0001-8048-3716
Ross A RobinsonImmunocore Ltd. , Abingdon, UK.ORCID 0000-0002-1482-0910
Gurdyal S BesraSchool of Biosciences, Institute of Microbiology and Infection, University of Birmingham , Edgbaston, UK.ORCID 0000-0002-5605-0395
Marc W van der KampSchool of Biochemistry, University of Bristol, Bristol, UK.ORCID 0000-0002-8060-3359
Lucia MoriExperimental Immunology, Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.ORCID 0000-0002-5522-4648
Raffaele CalogeroDepartment of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.ORCID 0000-0002-2848-628X
David K Cole *Immunocore Ltd. , Abingdon, UK.ORCID 0000-0003-0028-9396
Gennaro De Libero *Experimental Immunology, Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.ORCID 0000-0003-0853-7868
Marco Lepore *Immunocore Ltd. , Abingdon, UK.ORCID 0000-0003-1353-8224
Immunocore (United Kingdom) · GBUniversity of Basel · CHUniversity of Bath · GBUniversity of Birmingham · GBUniversity of Bristol · GBUniversity of Turin · IT

Funding

Biotechnology and Biological Sciences Research Council BB/M026280/1
6 · The paper itself

Abstract

Mucosal-associated invariant T (MAIT) cells use canonical semi-invariant T cell receptors (TCR) to recognize microbial riboflavin precursors displayed by the antigen-presenting molecule MR1. The extent of MAIT TCR crossreactivity toward physiological, microbially unrelated antigens remains underexplored. We describe MAIT TCRs endowed with MR1-dependent reactivity to tumor and healthy cells in the absence of microbial metabolites. MAIT cells bearing TCRs crossreactive toward self are rare but commonly found within healthy donors and display T-helper-like functions in vitro. Experiments with MR1-tetramers loaded with distinct ligands revealed significant crossreactivity among MAIT TCRs both ex vivo and upon in vitro expansion. A canonical MAIT TCR was selected on the basis of extremely promiscuous MR1 recognition. Structural and molecular dynamic analyses associated promiscuity to unique TCRβ-chain features that were enriched within self-reactive MAIT cells of healthy individuals. Thus, self-reactive recognition of MR1 represents a functionally relevant indication of MAIT TCR crossreactivity, suggesting a potentially broader role of MAIT cells in immune homeostasis and diseases, beyond microbial immunosurveillance.

Indexed as

Mucosal-Associated Invariant T CellsCell CommunicationCell MembraneCross ReactionsDNA RepairHistocompatibility Antigens Class IHumansMinor Histocompatibility AntigensHistocompatibility Antigens Class IMinor Histocompatibility AntigensMR1 protein, human

Identifiers

PMID37382893
PMCPMC10309188
OpenAlexW4382502813

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.